Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion (Q35963400)

11 August 2017

Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion (English)

1 reference

11 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Iwei Yeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Thomas Botton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Boris C. Bastian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Richard Scolyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Georgina V. Long

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Georgina V Long

1 reference

11 August 2017

5

Richard A Scolyer

1 reference

11 August 2017

1

Alexander M Menzies

1 reference

11 August 2017

Iwei Yeh

2

1 reference

11 August 2017

Thomas Botton

3

1 reference

11 August 2017

Boris C Bastian

4

1 reference

11 August 2017

15 June 2015

1 reference

Pigment Cell & Melanoma Research

11 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

607-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance

13 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26072686

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/PCMR.12388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference